What to Expect After Spinal Cord Stimulator Surgery

Recovery from spinal cord stimulator (SCS) surgery follows a fairly predictable arc: a few weeks of restricted movement while incisions heal, a programming phase where your care team fine-tunes the device’s electrical settings, and then a longer period of adjusting to life with an implant. Most people leave the hospital the same day or the next morning, and the initial surgical soreness fades within two to four weeks. The more interesting question is what happens after that early window, because the device itself takes time to optimize, and the long-term picture involves a mix of encouraging pain-relief data, practical lifestyle adjustments, and hardware realities that are worth understanding before you go in.

The First Few Weeks After Implantation

The incision sites (typically one along the spine where the leads were placed and another where the pulse generator sits, often near the hip or buttock) will be sore, swollen, and bruised. Your surgeon will likely restrict bending, twisting, and lifting anything heavier than a few pounds for roughly four to eight weeks. These restrictions exist to prevent the thin leads from shifting out of position before scar tissue anchors them in place. You’ll be asked to keep the incisions clean and dry, and most people are prescribed a short course of oral antibiotics.

Some swelling around the generator pocket is normal. Occasionally, fluid can collect under the skin at the incision site, forming what surgeons call a seroma. These serous fluid collections range from barely noticeable to visibly puffy, and they can show up anywhere from days to months after the procedure. Most resolve on their own with gentle pressure dressings; persistent ones sometimes need to be drained with a needle. Hematomas, or localized blood collections, are also possible. A pooled analysis of studies found that hematomas occur in under 1% of SCS implants overall, and smaller superficial ones typically clear up without treatment.¹ Larger or expanding hematomas may need surgical drainage, but that’s uncommon.

Infection is the complication people worry about most. The numbers are reassuring but not zero. A large U.S. payer database study found that about 3% of SCS patients experienced an infection event within 12 months.² A separate multicenter retrospective study reported an overall infection rate of roughly 2.5%, and found that using an occlusive wound dressing and post-operative antibiotics were both associated with lower infection rates.³ If an infection does develop, it usually presents with increasing redness, warmth, or drainage at the incision within the first weeks. Caught early, many infections respond to antibiotics alone, but deeper infections sometimes require device removal.

Programming the Device

Getting the stimulator turned on is not a one-and-done event. Your first programming session usually happens before you leave the hospital or within a few days, and follow-up adjustments over the next several weeks are standard. The goal is to find the combination of electrical settings that gives you the best pain relief with the fewest side effects. Expect multiple office visits during the first one to three months as your clinician tests different programs.

If you have a traditional low-frequency stimulator, you’ll feel a tingling or buzzing sensation called paresthesia in the area where you normally have pain. Some people find this pleasant and reassuring; others find it annoying. The stimulation needs to “cover” your pain area to work, so repositioning the electrical field through programming adjustments is common. Newer high-frequency devices, like those delivering stimulation at 10 kHz, work differently. Clinical data show that high-frequency SCS does not depend on producing paresthesia overlapping the painful area, and patients typically report no apparent sensory disturbance, numbness, or altered function during therapy.⁴ In practical terms, if you have a paresthesia-free device, you may not feel anything happening when the stimulator is on, which can be disconcerting at first but is normal.

How Much Pain Relief to Expect

The standard benchmark in spinal cord stimulation research is whether a patient achieves at least 50% reduction in pain. By that measure, the results are generally favorable but vary by person. A real-world study of 505 consecutive SCS trials found that about 86% of patients hit the 50% threshold during their initial trial period. Among those who went on to permanent implantation, roughly 77% still reported meaningful improvement in pain and function at their last follow-up, with an average pain improvement of about 57%.⁵

High-frequency stimulation has produced some of the more striking numbers. In a European multicenter study, patients with chronic back pain saw their average pain scores drop from 8.4 out of 10 down to 2.7 at six months, and about three-quarters achieved greater than 50% back pain relief.⁶ Those are averages, though, and individual experiences range widely. Some people get near-complete relief; others get modest improvement that still makes a meaningful difference in daily life; and a subset find the device doesn’t help enough to justify keeping it.

The underlying condition matters too. Burst stimulation, a different waveform pattern, showed an additional 44% pain reduction beyond conventional stimulation in patients with painful diabetic neuropathy and about 28% additional reduction in failed back surgery syndrome patients.⁷ The point is that the type of pain you have and the stimulation waveform your device uses both influence where you’ll land on the outcome spectrum.

Effects on Opioid Use and Sleep

Many people considering SCS are already taking opioids and hope the stimulator will let them reduce or stop. The evidence here is mixed. A review of clinical studies on 10 kHz stimulation found that over 60% of patients in studies either reduced or eliminated opioids at their last follow-up, with treatment providing at least 50% pain relief in more than 70% of patients after at least a year.⁸ A larger analysis using machine learning on over 7,000 SCS patients defined success as opioid dose stability or reduction at one year and found that about 67% met that benchmark.⁹

A word of realism, though: a study using U.S. insurance claims data found that among patients already on long-term opioid therapy before SCS, nearly the same proportion remained on opioids afterward whether or not they received the stimulator.¹⁰ This suggests that while SCS can create the conditions for opioid tapering, the tapering itself often requires deliberate effort with your prescribing physician. The device alone doesn’t automatically solve the opioid piece.

Sleep is another area that frequently improves. In a randomized controlled trial subanalysis, patients treated with closed-loop SCS gained roughly an additional hour of sleep per night by the 12-month mark, with improvements showing up as early as one month.¹¹ A smaller study separately found that insomnia symptoms improved significantly after SCS, and those improvements correlated with the degree of pain reduction.¹² An extra hour of sleep may not sound dramatic on paper, but for someone who has been averaging five hours a night because of pain, it’s a substantial quality-of-life change.

Everyday Life with the Device

Once you’ve healed and your programming is dialed in, the device becomes part of your daily routine. If you have a rechargeable pulse generator, that means regular charging sessions using an external belt or patch placed over the implant site. Depending on your stimulation settings and battery size, you might charge daily for 30 to 60 minutes or every few days. Rechargeable systems last longer before needing surgical battery replacement, but the tradeoff is the ongoing maintenance commitment.¹³ Non-rechargeable systems are more hands-off but need surgical replacement when the battery runs down, typically every three to five years depending on usage.

Driving is one of the first questions people ask. A survey of 78 SCS patients found that 97% were active drivers and 80% reported using their stimulator consistently while behind the wheel for pain relief. The motor vehicle accident rate in this group was about 11%, and none of the accidents were attributed to the stimulator itself. Patients began driving with the device active at a median of about three weeks after implantation.¹⁴ Most surgeons advise waiting until you’re off prescription pain medication and feel comfortable turning your head and braking before getting behind the wheel, typically two to four weeks out.

Airport security and retail theft-detection systems deserve a mention. The electromagnetic fields generated by metal detectors and antitheft systems can occasionally interfere with implanted stimulators, and the FDA has received adverse event reports over the years describing such interference.¹⁵ You’ll carry a device identification card, and most patients simply ask for a manual pat-down rather than walking through the scanner. If you do walk through, move at a normal pace and don’t linger in the field. The risk is more about unexpected stimulation changes than anything dangerous, but it’s worth knowing about.

Medical Procedures and Safety Precautions

One of the less discussed realities of living with an SCS is that certain medical procedures become more complicated. MRI access is a common concern. Whether you can get an MRI depends on the specific device you have, the complete implanted configuration, and the conditions of the scan being requested. MR-conditional status is not a blanket “yes” for all scans but is specific to each setup.¹⁶ Some newer systems allow full-body MRI under defined conditions; older systems may only allow head scans, or none at all. Always confirm MRI compatibility with your device team before scheduling.

Several other procedures require caution. The FDA warns that diathermy, lithotripsy, external defibrillation, radiation therapy, high-output ultrasound, and certain other energy-based treatments can permanently damage the implant if the device is not turned off beforehand.¹⁷ If you need surgery for something unrelated to your SCS, make sure every member of your surgical team knows about the implant. Electrocautery, which is used in virtually every operating room, can interact with the device and needs to be managed carefully.

Hardware Problems and Revisions

SCS devices are sophisticated hardware living inside a moving body, and mechanical issues are not rare. Lead migration, where the thin electrode wires shift from their original position, is one of the most common reasons people need a follow-up procedure. When leads move, stimulation may no longer cover the right area, and reprogramming can sometimes compensate but not always. A short-term study of percutaneous leads with a 10 kHz device found no migrations requiring revision within six months, which is encouraging for newer anchoring techniques, but longer follow-up tells a different story for the broader SCS population.¹⁸

Among patients who do need at least one revision, the timing clusters early. About 69% of first revisions happen within the first year of implantation, and 89% occur within three years. Patients who need a second revision tend to need it on a similar timeline after their first, with a median gap of about 10 months.¹⁹ This doesn’t mean most patients need revisions, but if you’re going to have a hardware issue, you’ll likely know about it relatively early rather than years down the road.

When Effectiveness Fades

A frustrating reality of SCS is that the pain relief can diminish over time. Researchers describe this as a habituation phenomenon, where the nervous system gradually becomes accustomed to the electrical stimulation pattern, reducing its therapeutic effect. The process is thought to parallel pharmacological tolerance, where a drug loses potency at the same dose.²⁰ The development of newer waveforms like burst and high-frequency stimulation has given clinicians more tools to combat this. When one pattern loses effectiveness, switching to a different waveform can sometimes restore relief, which is one reason why having a device that supports multiple stimulation modes matters.

When reprogramming and waveform changes aren’t enough, explantation, or removal of the device, becomes an option. A systematic review spanning four decades of data and over 13,000 patients found that about 10% ultimately had their device removed. The most common reason was insufficient pain relief, accounting for 38% of explantations, followed by lead failure at 15% and infection at 14%.²¹ A single-center study with 15 years of follow-up reported a higher explantation rate of 30%, with biological complications, paresthesia-related side effects, hardware problems, and ineffective pain control each accounting for roughly a quarter of removals.²² The spread between 10% and 30% likely reflects differences in follow-up length, patient selection, and device technology across eras. Either way, explantation is a real possibility, but it’s also a relatively straightforward procedure since the device was designed to be removable.

Returning to Work

Pain relief and functional recovery don’t always move in lockstep. Despite evidence that SCS can improve the prerequisites for returning to work, only about 10 to 14% of implanted patients actually make it back to employment.²³ That gap is striking and suggests that pain reduction alone isn’t sufficient for most people who have been out of the workforce due to chronic pain. Deconditioning, psychological factors like fear of re-injury, workplace accommodations, and the complex bureaucracy of disability benefits all play a role. Research is actively exploring whether structured biopsychosocial rehabilitation programs after SCS can close this gap, but the honest takeaway right now is that while the stimulator can be a powerful piece of the puzzle, going back to work usually requires deliberate rehabilitation beyond just turning the device on.

Physical therapy after the initial healing window is something worth discussing with your care team. Many clinicians encourage a graded return to activity starting around six to eight weeks, but there isn’t a single universal protocol. Walking is typically encouraged from day one, and most patients return to light daily activities within a few weeks. More demanding physical tasks, including gym workouts and manual labor, usually get clearance around the two- to three-month mark, depending on how the leads are settling and how your pain is responding.